Expanding the Diagnostic Horizon in COPD: Insights from GOLD 2025 on Early Detection and Comprehensive Assessment

The 2025 update to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines redefines the chronic obstructive pulmonary disease (COPD) diagnostic framework by recognizing earlier-stage conditions like "pre-COPD" and "PRISm" (preserved ratio impaired spirometry). This new approach captures patients who display early symptoms or structural changes in the lungs but do not yet meet traditional COPD criteria, marking a shift toward early detection and personalized management. By broadening the diagnostic criteria and promoting advanced imaging and biomarker use, GOLD 2025 offers pulmonologists a more precise, individualized approach to assessing COPD. This article examines the implications of these diagnostic updates for clinical practice, emphasizing the importance of proactive intervention to improve outcomes, slow disease progression, and tailor treatment to the unique profiles of at-risk patients. By embracing diverse pathophysiological profiles, the new GOLD framework underscores the necessity for comprehensive diagnostic tools, including imaging and biomarker analyses, to redefine COPD as a preventable and manageable condition.